lnc-SNHG1 | |||||||
---|---|---|---|---|---|---|---|
Total cases | High expression (n = 37) | Low expression (n = 58) | χ2 | P | |||
Age (year) | n | n | % | n | % | 0.074 | 0.786 |
Postmenopausal (< 50) | 42 | 17 | 40.48 | 25 | 59.52 | ||
Premenopausal (≧50) | 53 | 20 | 37.74 | 33 | 62.26 | ||
Tumor stage (FIGO) | 8.435 | 0.015 | |||||
I-II | 21 | 4 | 19.05 | 17 | 80.95 | ||
III | 45 | 16 | 35.56 | 29 | 64.44 | ||
IV | 29 | 17 | 58.62 | 12 | 41.38 | ||
Histological grade (n = 88) | 6.529 | 0.011 | |||||
H | 72 | 34 | 47.22 | 38 | 52.78 | ||
L | 16 | 2 | 12.50 | 14 | 87.50 | ||
Nodal status (n) | 13.323 | 0.0001 | |||||
Negative | 60 | 15 | 25.00 | 45 | 75.00 | ||
Positive | 35 | 22 | 62.86 | 13 | 37.14 | ||
Tumor diameter (cm) | 0.343 | 0.842 | |||||
< 10 cm | 30 | 12 | 40.00 | 18 | 60.00 | ||
10–20 cm | 58 | 23 | 39.66 | 35 | 60.34 | ||
> 20 cm | 7 | 2 | 28.57 | 5 | 71.43 | ||
Chemotherapy | 31.148 | 0.0001 | |||||
Chemoresistance | 32 | 25 | 78.13 | 7 | 21.87 | ||
Chemosensitivity | 63 | 12 | 19.05 | 51 | 80.95 | ||
Metastasis | 25.499 | 0.0001 | |||||
Y | 19 | 17 | 89.47 | 2 | 10.53 | ||
N | 76 | 20 | 26.32 | 56 | 73.68 |